Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05485545
Other study ID # CHUBX 2019/39
Secondary ID 2021-A00770-41
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date September 1, 2022
Est. completion date September 1, 2024

Study information

Verified date July 2022
Source University Hospital, Bordeaux
Contact Xavier IRART, MD
Phone (0)5 57 65 64 65
Email xavier.iriart@chu-bordeaux.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this work is to estimate the correlation between the electrical activation of the VD measured by the CARTO electrophysiological mapping system and the mechanical activation of the VD measured by 3D echocardiography and 3D speckle-tracking. Our hypothesis is that there is a strong correlation between electrical activation and mechanical activation in patients with an operated Fallot tetralogy.


Description:

Fallot tetralogy is the most common cyanogenic congenital heart disease. Thanks to advances in surgery, most patients survive to adulthood but develop a failure of the function of the right ventricle and then of the left ventricle resulting in progressive heart failure and death of patients. Despite corrective surgeries in adulthood, including pulmonary valve surgery, heart failure remains a major problem. One of the mechanisms of this heart failure is the right intraventtricular asynchronism associated with the postoperative right branch block, which will secondaryly become complicated from an interventricular asynchronism for left intraventtricular, partly explaining the overall progressive failure of cardiac function. To date, there is no model for combining a combined analysis of electrical and mechanical activation in the same patients. Understanding these mechanisms would allow us to better understand the pathophysiology of heart failure in this population and to propose targeted therapies to prevent this asynchronism by adapting surgical techniques, or treating this asynchronism with electrical therapy such as bivascular resynchronization. Each patient in each group will perform, according to standard practice, an electrophysiological exploration with mapping of the heart using the CARTO system, a cardiac MRI and a 3-dimensional transthoracic echocardiography. The follow-up of each patient takes place during a scheduled hospitalization as part of the care. Their participation in the study only lasts for the duration of the hospitalization.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date September 1, 2024
Est. primary completion date September 1, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Inclusion Criteria in the Fallot group - Male or female patient aged 18, - Patient with Fallot Tetralogy operated. nclusion Criteria in the Control group - Male or female patient aged 18, - Patient benefiting from electrophysiological exploration for a healthy heart arrhythmia, - Patient with a significant lack of heart disease. Exclusion Criteria: Exclusion Criteria in the Fallot group - Patient with associated left heart disease, - Patient with an acoustic window that does not allow for proper echocardiography, - Patient with contraindication to MRI, - Woman of childbearing age without effective contraception (HAS criteria) or Pregnant (ßHCG > 20 IU/l) or nursing woman. Exclusion Criteria in the Control group - Patient with an acoustic window that does not allow proper echocardiography, - Patient with MRI contraindication, - Woman of childbearing age without effective contraception (HAS criteria) or Pregnant (ßHCG > 20 IU/l) or nursing woman, - Cardiac pathology detected during echocardiography.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Electrophysiological exploration of the right ventricle
CARTO electrophysiological mapping system 3D echocardiography High Resolution MRI

Locations

Country Name City State
France CHU de Bordeaux Bordeaux

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Bordeaux Reference Centre for Rare Diseases Malformations Congenital Heart Complexes (CRMR M3C-Bordeaux)

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Comparison of electrical and mechanical activation by computational morphometry with temporal recalling to define electromechanical activation maps in healthy subjects and patients with Fallot tetralogy operated. Day 0
Secondary Area strain VD 3D global in % Global 3D VD longitudinal strain in %, Global 3D VD circumferential strain in %, Mean deformation pattern, Mean RV right ventricle shape, RV Average Curvature Index. Day 0
Secondary Strain longitudinal VD 3D at the 8 segments in % Day 0
Secondary Strain circumferential VD 3D at the 8 segments in % Day 0
Secondary Comparison of 3D VD volume data between different populations 3D VD Ejection Fraction and End-Diastolic and End-Systolic Volume 3D VD; 3D right ventricle volume data processed by Tomtec 4D RV Function 2.0. Day 0
Secondary Inter-evaluator variability of 3D deformation parameters Area strain 3D in %, Longitudinal strain in %, Circumferential strain in %, Global 3D at right ventricle level. Day 0
Secondary Intra-evaluator variability of 3D deformation parameters Area strain 3D in %, Longitudinal strain in %, Circumferential strain in %, Global 3D at right ventricle level. Day 0
Secondary MR Analysis Right and Left Ventricular MRI Volumetry;
Pulmonary flow by MRI.
T1 spontaneous (ms) and extracellular volume fraction (%) by MRI
MRI scar area
Day 0
Secondary Comparison of electrical activation maps based on anatomical data Comparison of electrical activation maps based on anatomical data, including diffuse fibrosis and scars in Fallot subjects Day 0
See also
  Status Clinical Trial Phase
Completed NCT02534792 - Early Revalvulation After Fallot Repair Improves Clinical Outcome N/A
Completed NCT00536432 - Early Re-intervention in Infants and Small Children After Correction of Tetralogy of Fallot N/A
Completed NCT01941576 - Effects of rhBNP in Pediatrics After Corrective Repair of Tetralogy Of Fallot N/A
Active, not recruiting NCT03983512 - PULSTA Transcatheter Pulmonary Valve Pre-Approval Study N/A
Recruiting NCT04581668 - Impact of NAVA Ventilation on Brain Oxygenation and Perfusion in Children With Congenital Heart Disease N/A
Completed NCT01762124 - Study of the Native Outflow Tract Transcatheter Pulmonary Valve (TPV) N/A
Active, not recruiting NCT02161471 - Haemodynamics and Function of the Atria in Congenital Heart Disease by Cardiovascular Magnetic Resonance
Not yet recruiting NCT05916976 - Repaired Tetralogy of Fallot: Risc Score From MRI & Clinical Data to Predict the Need for Change of Treatment N/A
Recruiting NCT04106479 - NIRS in Congenital Heart Defects - Correlation With Echocardiography
Completed NCT05579964 - The Role of Dexmedetomidine as Myocardial Protector in Pediatric Cardiac Surgery Total Correction of Tetralogy of Fallot Phase 2/Phase 3
Recruiting NCT05236153 - Electroanatomic Interactions Between Transcatheter Pulmonary Valve Prostheses and Anatomic Isthmuses in Repaired Tetralogy of Fallot N/A
Recruiting NCT03049995 - Stress Echo 2020 - The International Stress Echo Study
Completed NCT02586740 - Retrospective Review of Anesthetic Considerations for Pulmonary Artery Rehabilitation N/A
Terminated NCT00564993 - Cardiac Function Under Stress for Early Detection of the Right Ventricular Insufficiency After Repair of Tetralogy of Fallot Phase 3
Recruiting NCT05122962 - Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart Diseases
Completed NCT06097377 - Lymphatic Magnetic Resonance Imaging Abnormalities in Children With Tetralogy of Fallot: A Case-Control Study
Completed NCT03835494 - Analysis of RV-Dysfunction in Fallot Patients N/A
Not yet recruiting NCT03275844 - Physical Capacity and Activity in Children With Congenital Heart Disease N/A
Recruiting NCT02590679 - Multi-center Trial of Percutaneous Pulmonary Valve Implantation With Venus-p Phase 2/Phase 3
Recruiting NCT00155428 - Biomodel in Tetralogy of Fallot N/A